Collection search - Proprietary or patent medicine registers [textual record]

Record information – Brief
1
Proprietary or patent medicine registers [textual record]

Hierarchical level:

Series

Date:

1917-1976.

Reference:

R227-243-X-E, RG29

Type of material:

Textual material

Found in:

Archives / Collections and Fonds

Item ID number:

4166220

Context of this record:

Show detail Hide detail

Department of Health fonds

Health Protection Branch sous-fonds

Proprietary or patent medicine registers
Link to this record

Add to My Research

Link to this record

This link identifies the web page describing this particular record. Unlike the temporary link in your browser, this link will allow you to access, and reference, this page in the future. To link to this descriptive record, copy and paste the URL where ever needed (wiki, blog, document).

Sign in

Sign in to start saving records using My Research

Sign in
Record information – Details

Series includes:

6 lower level description(s)
View lower level description(s)

Date(s):

1917-1976.

Bilingual equivalent:

Click here

Place of creation:

Canada

Extent:

0.3 m of textual records

Language of material:

English

Accession:

Show detail Hide detail

Proprietary or Patent Medicine Act Advisory Board Meeting Minutes, Submissions, and License Numbers. [textual record]

Scope and content:

Show detail Hide detail

The records in this series consist of administrative ledgers, lists, and certificates related to the registration of medicines under the Proprietary or Patent Medicine Act; see lower-level descriptions for details.

Additional name(s):

Show detail Hide detail

Canada. Health and Welfare Canada

Additional information:

Show detail Hide detail

General note:

Show detail Hide detail

The Proprietary or Patent Medicine Act, assented to 20 July 1908, required the registration of secret-formula, non-pharmacopoeial packaged medicines for internal use. The Act introduced certain labelling requirements and prohibited the inclusion of cocaine or any of its salts in secret-formula medicines. The Act also limited the amount of alcohol and certain scheduled drugs (e.g., arsenical preparations, heroin, Indian hemp) that could be included in the secret-formula medicines. There were several subsequent amendments to the Act's schedule, and regulations were established 9 January 1911.

The administration of the Act was initially the responsibility of the Department of Inland Revenue, and then the Department of Trade and Commerce. A major amendment to the Act occured 7 July 1919 to prohibit false, misleading, or exaggerated label claims. Responsibility for the administration of the Proprietary or Patent Medicine Act was transferred to the newly created Department of Health on 1 September 1919.

The number of preparations registered under the Act varied. There were an estimated 60,000 preparations registered under the Act of 1908, but subsequent to the 1919 amendments to the Act, the number of registrations under the Act of 1919 dropped to less than 6,000. By the mid 1970s, there were approximately 1,700 preparations registered under the Act.

The Act was repealed effective 1 July 1976. The general function of registering proprietary medicines continued under the Food and Drugs Act, specifically Division 10 of the Food and Drug Regulations, with Health and Welfare Canada's Bureau of Drugs issuing G.P. numbers.

Source of title:

Title based on the contents of the series.

Accruals:

No further accruals are expected.

Source:

Government

Related control no.:

Show detail Hide detail

2011-00044-0
2013-00422-2
616090
RG29

Former archival reference no.:

Show detail Hide detail

RG29
Ordering and viewing options

Conditions of access:

Show detail Hide detail

Textual records

[Consultation32 Restricted by law]

Volume [R227] 3720--3724

[Consultation 32 Restricted by law]

Terms of use:

Show detail Hide detail

Copyright belongs to the Crown.

You can order materials in advance to be ready for you when you visit. You will need a user card to do this.

Cannot visit us on site? You can purchase a copy to be sent to you. Some restrictions may apply.

Report a problem on this page

Date modified:: 2024-04-09